Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 39
2022 87
2023 56
2024 21
2025 10
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Fluvoxamine for the treatment of COVID-19.
Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C. Nyirenda JL, et al. Cochrane Database Syst Rev. 2022 Sep 14;9(9):CD015391. doi: 10.1002/14651858.CD015391. Cochrane Database Syst Rev. 2022. PMID: 36103313 Free PMC article.
Fluvoxamine has not been approved for the treatment of infections, but has been used in the early treatment of people with mild to moderate COVID-19. ...Fluvoxamine for the treatment of COVID-19 in inpatients We did not identify any compl …
Fluvoxamine has not been approved for the treatment of infections, but has been used in the early treatment of people with mild to mo …
Lack of Benefit of Fluvoxamine for COVID-19.
Bhimraj A, Gallagher JC. Bhimraj A, et al. JAMA. 2023 Jan 24;329(4):291-292. doi: 10.1001/jama.2022.23954. JAMA. 2023. PMID: 36633871 No abstract available.
Mechanisms of action of fluvoxamine for COVID-19: a historical review.
Hashimoto Y, Suzuki T, Hashimoto K. Hashimoto Y, et al. Mol Psychiatry. 2022 Apr;27(4):1898-1907. doi: 10.1038/s41380-021-01432-3. Epub 2022 Jan 7. Mol Psychiatry. 2022. PMID: 34997196 Free PMC article. Review.
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accelerates the discovery of prophylactic and therapeutic …
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory …
Fluvoxamine and COVID-19.
El-Alfy AT, Busse K. El-Alfy AT, et al. WMJ. 2022;121:P2. WMJ. 2022. PMID: 35671339 Free article. No abstract available.
Fluvoxamine for COVID-19?
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 May 3;63(1623):69-70. Med Lett Drugs Ther. 2021. PMID: 33976099 No abstract available.
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
Lee TC, Vigod S, Bortolussi-Courval É, Hanula R, Boulware DR, Lenze EJ, Reiersen AM, McDonald EG. Lee TC, et al. JAMA Netw Open. 2022 Apr 1;5(4):e226269. doi: 10.1001/jamanetworkopen.2022.6269. JAMA Netw Open. 2022. PMID: 35385087 Free PMC article.
IMPORTANCE: Widely available and affordable options for the outpatient management of COVID-19 are needed, particularly for therapies that prevent hospitalization. OBJECTIVE: To perform a meta-analysis of the available randomized clinical trial evidence for fluvox …
IMPORTANCE: Widely available and affordable options for the outpatient management of COVID-19 are needed, particularly for the …
Fluvoxamine for the treatment of COVID-19.
Dodds MG, Doyle EB, Reiersen AM, Brown F, Rayner CR. Dodds MG, et al. Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7. Lancet Glob Health. 2022. PMID: 35180412 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Kim H, Manzi S, Gonzelez-Heydrich J, Picker J. Kim H, et al. Lancet Glob Health. 2022 Mar;10(3):e330. doi: 10.1016/S2214-109X(22)00003-1. Lancet Glob Health. 2022. PMID: 35180410 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Boulware DR, Abassi M. Boulware DR, et al. Lancet Glob Health. 2022 Mar;10(3):e329. doi: 10.1016/S2214-109X(21)00590-8. Lancet Glob Health. 2022. PMID: 35180409 Free PMC article. No abstract available.
195 results